Literature DB >> 22858435

Compromised neutrophil function and bovine E. coli mastitis: is C5a the missing link?

Mieke G H Stevens1, Bart De Spiegeleer, Luc Peelman, Xanthippe J A Boulougouris, Anthony V Capuco, Christian Burvenich.   

Abstract

During early lactation, dairy cow are prone to developing severe mastitis in responses to intramammary Escherichia coli infections. These severe inflammatory responses have been correlated with reduced neutrophil function during the periparturient period. However, the causative mechanism of neutrophil dysfunction has not been elucidated. Studies in murine sepsis models have shown that during sepsis neutrophils are functionally paralysed due to the presence of high concentrations of complement factor 5a (C5a). In this review, we hypothesize that C5a as a critical early mediator in the development of severe E. coli mastitis. Furthermore, preliminary data suggest that crosstalk between C5a and TLR4 signalling in neutrophils may provide a positive feedback mechanism that may be involved in the pathogenesis of a severe mastitis response. Finally, we focus on the therapeutic potential of disrupting the C5a signalling pathway as an important strategy for treatment of severe E. coli mastitis in dairy cattle.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858435     DOI: 10.1016/j.vetimm.2012.07.002

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  2 in total

1.  Immunomodulation of IL-1, IL-6 and IL-8 cytokines by Prosopis juliflora alkaloids during bovine sub-clinical mastitis.

Authors:  Kunal N Shah; Piyush Valand; Dev S Nauriyal; C G Joshi
Journal:  3 Biotech       Date:  2018-09-14       Impact factor: 2.406

2.  Non-classical proIL-1beta activation during mammary gland infection is pathogen-dependent but caspase-1 independent.

Authors:  Koen Breyne; Steven K Cool; Dieter Demon; Kristel Demeyere; Tom Vandenberghe; Peter Vandenabeele; Harald Carlsen; Wim Van Den Broeck; Niek N Sanders; Evelyne Meyer
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.